Clinical Trials List
2007-03-01 - 2008-05-31
Phase III
Terminated5
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chong-Jen Yu Division of Thoracic Medicine
- Shan-Chwen Chang Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tzeng-Ji Chen Division of Family Medicine
- Liang-Kung Chen Division of Family Medicine
- 林明憲 Division of Family Medicine
- 劉瑞瑤 Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ying-Huang Tsai 副院長，胸腔科副教授
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 謝世良 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
500 participants
-
Global
1090 participants
